The Translational Medicine & Clinical Pharmacology post-doctoral fellowship will leverage the skillsets acquired in a PharmD program, and train the Fellow for a career in the pharmaceutical industry. The Fellow will be based at Boehringer Ingelheim’s U.S. headquarters in Ridgefield, CT, working on a specific or multiple therapeutic areas (TAs) in the areas of cardiology, diabetes, immunology, oncology, and respiratory. This position will provide an opportunity for the Fellow to be involved in various cross functional teams within BI. The Fellow will also gain an understanding of the broad range of opportunities available in the pharmaceutical industry.
As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development and delivery of our products to our patients and customers. Our global presence provides opportunities for all employees to collaborate internationally, offering visibility and the ability to directly contribute to the company's success. We realize that our strength and competitive advantage lie with our people. We support our employees in a number of ways to foster a healthy working environment, meaningful work, diversity and inclusion, mobility, networking and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees.
Duties & Responsibilities:
Work under the mentorship of a senior clinical pharmacologist in various aspects of drug development.
Develop a sound understanding of global regulatory guidances (FDA, EMA, PMDA, etc) and apply regulatory learnings essential to designing drug development strategy from a clinical pharmacology perspective.
Understand and apply drug-drug interaction guidances to conceptualize drug interaction risk, and subsequently design appropriate trials to elucidate the risk clinically.
Design the clinical PK/PD aspects of the clinical trial protocol (trials in healthy volunteers/patients) and analyze results (e.g., food effect studies, drug-drug interaction studies, formulation bridging studies, single rising dose studies, etc).
Author clinical pharmacology sections of documents (e.g., clinical trial protocols, clinical trial reports, investigator brochure, response to authority requests, etc.).
Review literature to find solutions to scientific challenges, design clinical trials and contribute to project strategies.
Present internally as well as externally (e.g., present at professional clinical pharmacology meetings) and coauthor scientific manuscripts depending on project needs.
Lab based work is not a requirement for this position.
Doctor of Pharmacy degree from an ACPE-accredited school or college of pharmacy earned prior to the start date at Boehringer Ingelheim.
Strong intrapersonal, active listening and problem-solving skills with an ability to work well in a team environment
Highly motivated and shows initiative in contributing to team deliverables
Receptive to receiving and quickly implementing constructive feedback
Ability to work independently within provided guidance from mentor/team leads
Adaptable and able to contribute to multiple therapeutic areas as needed
Excellent verbal and written communication skills
Proven experience working in a dynamic, high volume environment handling multiple tasks
Strong computer skills, including Outlook, Word, PowerPoint, and Excel.
Exposure to Phoenix WinNonLin and SigmaPlot would be an asset.
Prior pharmaceutical industry experience (e.g. internship or Advanced Pharmacy Practice Experience [APPE] rotation) is preferred but not required.
Must be legally authorized to work in the United States without restriction
Must be willing to take a drug test and post-offer physical (if required)
Must be 18 years of age or older
Additional Salary Information: The fellow will receive a competitive stipend and benefits package
About Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim is focused on science that leads to more health for our patients and their families. The discovery and development of innovative medicines is fundamental to our continued growth and success. Our blueprint for innovation is tailored to accelerate the delivery of breakthrough medicines to the patients we serve by integrating research, pre-clinical and early clinical development, translational medicine, and external partnering functions. This fusion of expertise combined with a dynamic research approach and an increased emphasis on external collaborations means we can effectively incubate the most creative ideas and be among the pioneers in emerging fields of medicine.